Literature DB >> 20011471

Botulinium toxin, as bridge to transanal pullthrough in neonate with Hirschsprungs disease.

S M V Hosseini1, H R Foroutan, S Zeraatian, B Sabet.   

Abstract

AIMS AND
OBJECTIVES: The aim of this study is to find easier way of home care while obviating the colostomy before single stage pull through operation.
MATERIALS AND METHODS: From August 2005 to December 2006, eight cases of neonatal Hirschsprung disease were treated. Mean age 4.5 (2-6) day/old with absent anorectal inhibitory reflex, rectosigmiod disease in Barium enema, positive Acetylcholine esterase (Ache) staining, good response to rectal washout. They underwent botulinium toxin injection (5 unit /kg/quadrant) in four quadrant intrasphincteric. They were followed until pull through operation in 8-10 weeks post injection.
RESULTS: Four of 8 (50%) cases only needed rectal washout for three to five days post injection until pull through operation, two had decrease in number of rectal washouts /day and the remaining two underwent colostomy five days post injection because of no response.
CONCLUSION: Botulinium toxin injection can help in palliative care in patients with Hirschsprung disease who are waiting for colostomy or definitive pullthrough. It gives an option of eaiser home care for these patients.

Entities:  

Keywords:  Botulinium toxin; Hirschsprung's disease; neonatal obstruction; pull through operation

Year:  2008        PMID: 20011471      PMCID: PMC2788448          DOI: 10.4103/0971-9261.43025

Source DB:  PubMed          Journal:  J Indian Assoc Pediatr Surg        ISSN: 0971-9261


  10 in total

1.  [Treatment of Hirschsprung disease by botulinum toxin A through anorectal injection].

Authors:  Yi-hua Du; Qiang Peng; Ming Liu; Yong Zhi; Hong Chen
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2005-03

2.  Transanal endorectal pull-through for Hirschsprung's disease.

Authors:  L De la Torre-Mondragón; J A Ortega-Salgado
Journal:  J Pediatr Surg       Date:  1998-08       Impact factor: 2.545

3.  Extra-anal mucosectomy: laparascopic-assisted endorectal pull-through using a prolapsing technique.

Authors:  Y Morikawa; K Hoshino; K Matsumura; S Yoshioka; J Yokoyama; M Kitajima
Journal:  J Pediatr Surg       Date:  1998-11       Impact factor: 2.545

4.  A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.

Authors:  R K Minkes; J C Langer
Journal:  J Pediatr Surg       Date:  2000-12       Impact factor: 2.545

5.  Perineal one-stage pull-through for Hirschsprung's disease.

Authors:  C T Albanese; R W Jennings; B Smith; B Bratton; M R Harrison
Journal:  J Pediatr Surg       Date:  1999-03       Impact factor: 2.545

6.  Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.

Authors:  J C Langer; E Birnbaum
Journal:  J Pediatr Surg       Date:  1997-07       Impact factor: 2.545

7.  Histology and function of the internal anal sphincter after injection of botulinum toxin.

Authors:  J C Langer; E E Birnbaum; R E Schmidt
Journal:  J Surg Res       Date:  1997-12       Impact factor: 2.192

8.  Hirschsprung's disease: a 20-year experience.

Authors:  R Reding; J de Ville de Goyet; S Gosseye; P Clapuyt; E Sokal; J P Buts; P Gibbs; J B Otte
Journal:  J Pediatr Surg       Date:  1997-08       Impact factor: 2.545

9.  Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm.

Authors:  Jacob C Langer
Journal:  J Pediatr Surg       Date:  2004-10       Impact factor: 2.545

Review 10.  Hirschsprung's disease: a search for etiology.

Authors:  P Puri; K Ohshiro; T Wester
Journal:  Semin Pediatr Surg       Date:  1998-08       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.